601 related articles for article (PubMed ID: 27697996)
1. Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer.
Liang Q; Chiu J; Chen Y; Huang Y; Higashimori A; Fang J; Brim H; Ashktorab H; Ng SC; Ng SSM; Zheng S; Chan FKL; Sung JJY; Yu J
Clin Cancer Res; 2017 Apr; 23(8):2061-2070. PubMed ID: 27697996
[No Abstract] [Full Text] [Related]
2. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
3. A novel faecal
Liang JQ; Li T; Nakatsu G; Chen YX; Yau TO; Chu E; Wong S; Szeto CH; Ng SC; Chan FKL; Fang JY; Sung JJY; Yu J
Gut; 2020 Jul; 69(7):1248-1257. PubMed ID: 31776231
[TBL] [Abstract][Full Text] [Related]
4. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of faecal
Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
[TBL] [Abstract][Full Text] [Related]
6. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
7. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
[TBL] [Abstract][Full Text] [Related]
8. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
9. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects.
Liang JQ; Wong SH; Szeto CH; Chu ES; Lau HC; Chen Y; Fang J; Yu J; Sung JJ
J Gastroenterol Hepatol; 2021 Apr; 36(4):1035-1043. PubMed ID: 32633422
[TBL] [Abstract][Full Text] [Related]
11. A New Biomarker of Fecal Bacteria for Non-Invasive Diagnosis of Colorectal Cancer.
Yao Y; Ni H; Wang X; Xu Q; Zhang J; Jiang L; Wang B; Song S; Zhu X
Front Cell Infect Microbiol; 2021; 11():744049. PubMed ID: 34976850
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
13. A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria.
Liang JQ; Zeng Y; Lau EYT; Sun Y; Huang Y; Zhou T; Xu Z; Yu J; Ng SC; Chan FKL
Cells; 2023 Apr; 12(9):. PubMed ID: 37174650
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fecal microbial markers in colorectal cancer detection.
Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
[TBL] [Abstract][Full Text] [Related]
15. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
Shah MS; DeSantis TZ; Weinmaier T; McMurdie PJ; Cope JL; Altrichter A; Yamal JM; Hollister EB
Gut; 2018 May; 67(5):882-891. PubMed ID: 28341746
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
17. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
19. Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis.
Zhang X; Zhu X; Cao Y; Fang JY; Hong J; Chen H
Cancer Med; 2019 Feb; 8(2):480-491. PubMed ID: 30636375
[TBL] [Abstract][Full Text] [Related]
20. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.
Beaulieu JF; Herring E; Kanaoka S; Tremblay É
Oncotarget; 2016 Mar; 7(12):14684-92. PubMed ID: 26895101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]